Fluvoxamine maleate
Pro Research Analysisby 
Searched over 200M research papers for "fluvoxamine maleate"
Fluvoxamine Maleate: Efficacy, Safety, and Pharmacokinetics
Introduction to Fluvoxamine Maleate
Fluvoxamine maleate is a selective serotonin reuptake inhibitor (SSRI) widely used for its antidepressant, antiobsessive-compulsive, and antibulimic properties. It functions by inhibiting the serotonin reuptake pump on the presynaptic neuronal membrane, thereby increasing serotonin levels in the synaptic cleft and enhancing serotonergic transmission .
Efficacy in Treating Depression
Comparison with Imipramine
Several studies have demonstrated the efficacy of fluvoxamine maleate in treating major depressive disorder. In a double-blind, placebo-controlled study, fluvoxamine (50-150 mg/day) was found to be as effective as imipramine (80-240 mg/day) in reducing depression symptoms, as measured by the Hamilton Rating Scale for Depression . Both medications showed significant therapeutic benefits over placebo, with fluvoxamine being well-tolerated and producing fewer anticholinergic side effects compared to imipramine .
Comparison with Chlorimipramine
In another study comparing fluvoxamine with chlorimipramine, both medications showed marked improvement in depressive symptoms over four weeks. However, fluvoxamine had fewer side effects, particularly those related to anticholinergic activity, making it a safer option for many patients .
Inpatient Studies
A study involving severely ill inpatients with major depression found fluvoxamine to be superior to both placebo and imipramine in improving clinical outcomes. The most common side effects were nausea and agitation, but these were generally mild and did not lead to a significant number of treatment withdrawals .
Safety and Tolerability
General Safety Profile
Fluvoxamine is generally well-tolerated, with common side effects including nausea, somnolence, and abnormal ejaculation. These side effects are typically mild to moderate and transient . Unlike tricyclic antidepressants, fluvoxamine does not exhibit significant anticholinergic or cardiotoxic effects, making it a safer option for many patients .
Special Populations
Patients with Liver Cirrhosis
In patients with liver cirrhosis, fluvoxamine's pharmacokinetics are altered, leading to higher plasma concentrations and a longer elimination half-life. It is recommended to lower the initial daily dose and carefully monitor these patients during dose adjustments .
Patients Undergoing Hemodialysis
For patients on maintenance hemodialysis, fluvoxamine was effective in treating mild depression. The drug's plasma concentration decreased by 22% during hemodialysis, and the time to reach steady-state concentration was longer compared to healthy individuals .
Pharmacokinetics and Bioequivalence
Absorption and Metabolism
Fluvoxamine is completely absorbed when administered orally, with peak plasma levels reached between 2 to 8 hours post-administration. The drug follows first-order kinetics with a half-life of approximately 14.9 hours . In bioequivalence studies, fluvoxamine tablets were found to be bioequivalent under both fasting and fed conditions, with no significant differences in absorption .
Animal Studies
Animal studies have shown that fluvoxamine is completely absorbed in various species, with its metabolites being inactive regarding aminergic uptake processes. The drug has a favorable therapeutic ratio, with low cardiotoxicity and no significant affinity for cholinergic receptors .
Conclusion
Fluvoxamine maleate is a highly effective and well-tolerated SSRI for the treatment of major depressive disorder and other conditions like obsessive-compulsive disorder and bulimia. It offers a safer side effect profile compared to tricyclic antidepressants and is effective in both outpatient and inpatient settings. Special considerations are necessary for patients with liver cirrhosis and those undergoing hemodialysis, but overall, fluvoxamine remains a valuable option in the pharmacological management of depression.
Sources and full results
Most relevant research papers on this topic